Tobam Biogen Inc. Transaction History

Tobam

$638 Million
Q2 2024

A detailed history of Tobam transactions in Biogen Inc. stock. As of the latest transaction made, Tobam holds 5,345 shares of BIIB stock, worth $1.04 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

5,345

Previous 5,345 -0.0%

Holding current value

$1.04 Million

Previous $1.24 Million -0.0%

% of portfolio

0.19%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$190.52 - $236.72 $917,925 - $1.14 Million	-4,818 Reduced 47.41%	5,345 $1.24 Million
Q1 2024 May 02, 2024	SELL	$212.02 - $267.71 $372,943 - $470,901	-1,759 Reduced 14.75%	10,163 $2.19 Million
Q4 2023 Jan 26, 2024	SELL	$222.59 - $267.94 $207,676 - $249,988	-933 Reduced 7.26%	11,922 $3.09 Million
Q3 2023 Oct 31, 2023	SELL	$253.3 - $285.89 $1.93 Million - $2.18 Million	-7,613 Reduced 37.19%	12,855 $3.3 Million
Q2 2023 Jul 31, 2023	SELL	$275.25 - $318.06 $10 Million - $11.6 Million	-36,364 Reduced 63.99%	20,468 $5.83 Million
Q1 2023 May 03, 2023	SELL	$256.56 - $292.34 $5.56 Million - $6.34 Million	-21,678 Reduced 27.61%	56,832 $15.8 Million
Q4 2022 Feb 02, 2023	SELL	$252.44 - $306.72 $10.2 Million - $12.4 Million	-40,554 Reduced 34.06%	78,510 $21.7 Million
Q3 2022 Nov 02, 2022	SELL	$194.69 - $268.46 $8.33 Million - $11.5 Million	-42,789 Reduced 26.44%	119,064 $31.8 Million
Q2 2022 Aug 02, 2022	SELL	$187.54 - $223.02 $2.97 Million - $3.53 Million	-15,840 Reduced 8.91%	161,853 $33 Million
Q1 2022 Apr 25, 2022	BUY	$193.77 - $244.14 $2 Million - $2.52 Million	10,314 Added 6.16%	177,693 $37.4 Million
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $8.42 Million - $10.8 Million	37,610 Added 28.98%	167,379 $40.2 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $3.25 Million - $4.23 Million	-11,475 Reduced 8.12%	129,769 $36.7 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $6.7 Million - $10.7 Million	-25,856 Reduced 15.47%	141,244 $48.9 Million
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $486,385 - $569,829	2,002 Added 1.21%	167,100 $46.7 Million
Q4 2020 Feb 03, 2021	SELL	$236.26 - $355.63 $1.75 Million - $2.63 Million	-7,389 Reduced 4.28%	165,098 $40.4 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $14 Million - $16.2 Million	52,837 Added 44.16%	172,487 $48.9 Million
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $10 Million - $13.3 Million	38,742 Added 47.88%	119,650 $32 Million
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $5.4 Million - $6.85 Million	-20,097 Reduced 19.9%	80,908 $25.6 Million
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $6.37 Million - $8.8 Million	-28,954 Reduced 22.28%	101,005 $30 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $2.7 Million - $3.02 Million	12,398 Added 10.55%	129,959 $30.3 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $14.9 Million - $16.4 Million	67,900 Added 136.73%	117,561 $27.5 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $10.8 Million - $16.8 Million	49,661 New	49,661 $11.7 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account